Evogene Ltd., together with its subsidiaries, operates as a computational biology company.
$0.27-17.78%
报价 2026-11-06
市值
$2.3M
EV
$-2.4M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -78.3%
$0.27$1.25
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| EVGNEvogene Ltd. | $2.3M | -17.8% | – | 30.9% | – | – | – | |
| MDCXMedicus Pharma Ltd. | $2.7M | +2.2% | – | 0% | – | – | – | |
| MBIOMustang Bio, Inc. | $2.7M | +0.2% | +10900.0% | 0% | – | – | – | |
| ONCOOnconetix, Inc. | $2.5M | +26.6% | +12.5% | 80.4% | – | – | – | |
| VIVSVivoSim Labs, Inc. | $2.3M | +0.1% | 0.0% | -100.8% | – | – | – | |
| REVBRevelation Biosciences, Inc. | $2.2M | +9.3% | – | 0% | – | – | – | |
| CANFCan-Fite BioPharma Ltd. | $2.1M | +1.3% | – | 100% | – | – | – | |
| BRTXBioRestorative Therapies, Inc. | $2.1M | +0.7% | +180.0% | 92.1% | – | – | – | |
| SXTP60 Degrees Pharmaceuticals, Inc. | $2.1M | -35.1% | +35.7% | 19.4% | – | – | – | |
| 同行中位数 | – | – | +35.7% | 9.7% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。